Get my own profile
Public access
View all12 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Mark S.P. SansomUniversity of OxfordVerified email at bioch.ox.ac.uk
- Heidi KoldsøScorpion TherapeuticsVerified email at scorpiontx.com
- Christian SieboldProfessor of Structural BiologyVerified email at strubi.ox.ac.uk
- Jan DomańskiCharm TherapeuticsVerified email at charmtx.com
- Chavent MatthieuCNRS researcherVerified email at ipbs.fr
- Simon NewsteadUniversity of OxfordVerified email at bioch.ox.ac.uk
- Carol V RobinsonProfessor of Chemistry University of OxfordVerified email at chem.ox.ac.uk
- Hsin-Yung YenInstitute of Biological Chemistry, Academia SinicaVerified email at omass.com
- Christopher G TateProgramme Leader, MRC Laboratory of Molecular Biology, CambridgeVerified email at mrc-lmb.cam.ac.uk
- Andreas PluckthunBiochemisches Institut, Universität ZürichVerified email at bioc.uzh.ch
- Robert BestSenior Investigator, National Institutes of HealthVerified email at helix.nih.gov
- SL RouseUKRI Future Leaders Fellow, Imperial College LondonVerified email at imperial.ac.uk
- Anna DuncanTenure-track Assistant Professor, Aarhus UniversityVerified email at chem.au.dk
- E Yvonne JonesThe Sir Andrew McMichael Professor of Structural Immunology, University of OxfordVerified email at strubi.ox.ac.uk
- Philip C. BigginProfessor of Computational Biochemistry, University of OxfordVerified email at bioch.ox.ac.uk
Follow
George Hedger
Vertex Pharmaceuticals, D. E. Shaw Research, University of Oxford
Verified email at vrtx.com